Modified fossa implants were used in all cases.
Cruciate-retaining (272 knees, 96%) and cruciate-substituting (12, 4%) implants were used.
In this study, zygoma, pterygoid and regular platform implants were used.
The techniques were taken a step further for a face transplant: 3D prints of surgical guides, plates and titanium implants, were used to reconstruct a patient's entire face.
In Brazil, where about 25,000 implants were used, the National Agency of Sanitary Vigilance recommended that recipients be examined by their doctors.
During some eight years on the market, the two implants were used in about 93,000 patients worldwide, about one-third of them in the United States.
The rate of 90-day readmission, 3-year revision surgery, recovery period, time savings in operating rooms, and the associated cost within three years of primary knee replacement implants were used as performance metrics.
To prevent interlocking effects from lateral bone attachments a polytetrafluoroethylene (PTFE) cap covering the vertical and the upper faces of the implants were used.
In 2007, the surgeon had arrived as a fellow at Oxford University in England just as problems with all-metal hips were emerging in England and Australia, two countries where the implants were used earlier than the United States.
Various implants were used.
Cylindrical implants were used in each patient.
